Massive Audio PAT50 Instrukcja Użytkownika Strona 3

  • Pobierz
  • Dodaj do moich podręczników
  • Drukuj
  • Strona
    / 46
  • Spis treści
  • BOOKMARKI
  • Oceniono. / 5. Na podstawie oceny klientów
Przeglądanie stron 2
ÖKG-Jahrestagung – Abstracts
J KARDIOL 2008; 15 (5–6)
139
Von der Forschung zur Klinik“
Chronic Heart Failure Leads to an Expanded Plasma
Volume and Pseudoanemia, But Does Not Lead To a
Reduction In The Bodys Red Cell Mass 044
C. Adlbrecht, S. Kommata, M. Huelsmann, T. Szekeres, C. Bieglmayer, G. Strunk,
G. Karanikas, R. Berger, D. Mörtl, K. Kletter, G. Maurer, I. M. Lang, R. Pacher
Abteilung für Kardiologie, Abteilung für Nuklearmedizin, Klinisches Institut für
Medizinische und Chemische Labordiagnostik, Universitätsklinik für Innere
Medizin II, Medizinische Universität Wien; Forschungsinstitut für Gesundheits-
management und Gesundheitsökonomie, WU-Wien (G. S.)
Background Chronic heart failure (CHF) is frequently associated
with a decreased hemoglobin level. Although in some patients renal
anemia may develop, the mechanisms underlying the decrease in
hemoglobin in isolated CHF remain largely unknown. We explored
robust determinants of anemia including red cell mass as well as
related markers and the plasma volume in patients with CHF with-
out renal dysfunction based on non-cardiac reasons.
Methods One-hundred consecutive CHF patients were enrolled.
The total red cell volume (RCV) was determined by a 51Cr assay.
Furthermore, serum ferritin, erythropoietin, hepcidin, and renal
function parameters were assessed. The influence of each factor on
hemoglobin concentrations was determined in a multiple regression
model.
Results Mean hemoglobin concentrations were slightly lower in
patients with CHF (13.7 ± 1.6 mg/dL) compared to a healthy control
group (14.6 ± 1.3 mg/dL). However, the RCV was not reduced
in CHF patients (CHF with decreased hemoglobin: 1718.8 ±
569.3 mL, CHF with normal hemoglobin: 1828.4 ± 641.3 mL,
healthy controls: 1634.4 ± 470.8 mL), and there was no severe defi-
ciency of iron or erythropoietin detectable in CHF patients. We
found that plasma volume levels were significantly higher in pa-
tients with CHF compared to healthy individuals, suggesting the
presence of pseudoanemia (p < 0.001). Correspondingly, the
plasma volume was the best predictor of hemoglobin concentrations
in the regression model applied (B = –0.483; p < 0.0001).
Conclusion Hemodilution leading to pseudoanemia is the key
determinant influencing hemoglobin levels in isolated CHF. The
observation that the RCV is normal in isolated CHF and there is no
iron- or erythropoietin deficiency is an argument against supple-
mentation therapy in this group of patients.
Incidence and Prognostic Impact of Coronary Flow
Restoration After Guidewire Insertion Before Balloon
Inflation in ST-Elevation Myocardial Infarction 084
C. Adlbrecht, K. Distelmaier, D. Gündüz, D. Bonderman, A. Kaider*, G. Christ,
I. M. Lang
Division of Cardiology, Department of Internal Medicine II, Medical University of
Vienna; Ludwig Boltzmann Institute for Cardiovascular Research, Vienna;
*Core Unit of Medical Statistics and Informatics, Vienna
Background and Objective ST-elevation myocardial infarction
(STEMI) is characterized by an acute thrombotic obstruction of the
coronary artery. Recent randomized clinical trials evaluating
thrombectomy have yielded conflicting results. Patient inclusion
and randomization in these trials was performed after the initial an-
giogram, but importantly, before guidewire insertion. We hypo-
thesized that guidewire insertion alone, prior to balloon inflation or
thrombectomy, may lead to flow restoration in the infarct related
coronary artery (IRA), and that this phenomenon influences mortal-
ity. This may represent an important confounder in thrombectomy
trials.
Methods Angiograms of 1012 consecutive STEMI patients be-
tween January 2003 and December 2005 were evaluated and TIMI
flow was graded at the time of the initial angiogram and after
guidewire insertion. The incidence of coronary flow restoration af-
ter sole guidewire insertion was assessed and patient baseline char-
acteristics were collected by chart review. Subsequently, death and
death dates of all patients with an initial TIMI 0 flow were assessed.
Results An initial TIMI 0 was present in 476 (47.0 %) individuals.
Of these, full angiographic data were available of 403 (84.7 %) pa-
tients. Coronary flow restoration immediately after guidewire inser-
tion occurred in 150/403 (37.2 %) patients with an initial TIMI 0.
Kaplan Meyer analysis revealed improved survival in patients with
flow restoration after guidewire insertion (p = 0.17). Furthermore,
in a Cox regression model, flow restoration after guidewire inser-
tion had significant impact on mortality (p = 0.041). Finally, revas-
cularization guidewire insertion was more likely in the right coro-
nary artery (HR = 2.291, CI = 1.387–3.786; p = 0.005).
Discussion Coronary flow restoration following guidewire inser-
tion is a frequent event in emergency STEMI percutaneous coro-
nary intervention and significantly influences long-term clinical
outcome. Thus the exact time point of randomization in thrombec-
tomy studies appears to be more important than previously ex-
pected.
Prognosis of Acute Coronary Syndrome at High
versus Low Altitude Yemeni Patients 001
M. Ali Al-Huthi
1
, Y. A. Raja’a
2
, M. Al-Noami
2
, A. Rashid Abdul Rahman
3
1
Faculty of Medicine, Thamar University, Yemen;
2
Faculty of Medicine and Health
Science, Sana’a University, Yemen;
3
Advanced Medical and Dental Institute,
Penang, and Cyberjaya University College of Medical Sciences Malaysia
Background A cohort study design was employed for this study,
aimed at evaluating the prognosis of acute coronary syndrome
(ACS) among Yemeni patients at high and low altitudes.
Methods 157 ACS patients from high and low altitudes were
evaluated from admission to CCU up to 12 months. We evaluated
the possible effect of altitude on the rate of the prevalence of ACS
risk factors, in-hospital complications and one year treatment and
outcome of ACS.
Results The mean age of ACS patients at low altitude region was
higher (58.2 ± 6.8 years vs 55.5 ± 8.8 years; p = 0.042). The mean
heart rate (HR) was higher for altitude patients (94.4 ± 19.3 beat/
min vs 83.7 ± 17.1 beat/min; p < 0.001). High altitude patients were
seen to have higher mean of CK-MB, WBC, total cholesterol, LDL-
C and TG than low altitude patients. The prevalence of past history
Jahrestagung der
Österreichischen Kardiologischen Gesellschaft
28. bis 31. Mai 2008, Salzburg
Abstracts
(in alphabetischer Reihenfolge nach Erstautoren)
For personal use only. Not to be reproduced without permission of Krause & Pachernegg GmbH.
Przeglądanie stron 2
1 2 3 4 5 6 7 8 ... 45 46

Komentarze do niniejszej Instrukcji

Brak uwag